Published in Methods Enzymol on January 01, 2005
Protein nitration in cardiovascular diseases. Pharmacol Rev (2002) 1.58
Retracted Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem (2009) 1.56
Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich) (2008) 1.50
Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci (Landmark Ed) (2009) 1.40
Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J Biol Chem (2003) 1.35
Regulation of nitric oxide and soluble guanylyl cyclase. Brain Res Bull (2004) 1.30
Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Eng (2005) 1.29
The nature of heme/iron-induced protein tyrosine nitration. Proc Natl Acad Sci U S A (2003) 1.28
Nitric oxide (NO)--biogeneration, regulation, and relevance to human diseases. Front Biosci (2003) 1.26
Quantitative protein profiling in heart mitochondria from diabetic rats. J Biol Chem (2003) 1.21
Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc Natl Acad Sci U S A (2003) 1.20
Ligand selectivity of soluble guanylyl cyclase: effect of the hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide, and carbon monoxide. J Biol Chem (2006) 1.17
Soluble guanylyl cyclase: the nitric oxide receptor. Methods Enzymol (2005) 1.17
A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation. Proc Natl Acad Sci U S A (2003) 1.08
NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res (2006) 1.08
Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes. Nitric Oxide (2005) 1.07
Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci U S A (2008) 1.04
Resonance Raman and infrared spectroscopic studies of high-output forms of human soluble guanylyl cyclase. J Am Chem Soc (2005) 0.97
Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity. J Biol Chem (2008) 0.97
Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag (2011) 0.96
Nitric oxide accelerates the recovery from burn wounds. World J Surg (2007) 0.96
Nitric oxide: a guardian for vascular grafts? Chem Rev (2011) 0.95
Generation and role of angiostatin in human platelets. Blood (2003) 0.95
Differential expression of nitric oxide signaling components in undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev (2006) 0.95
A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Handb Exp Pharmacol (2009) 0.95
Upregulation of S100 calcium-binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen. FEBS Lett (2008) 0.92
Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea. Proc Natl Acad Sci U S A (2008) 0.92
Effects of nitric oxide on skin burn wound healing. J Burn Care Res (2008) 0.92
Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration. Proc Natl Acad Sci U S A (2006) 0.92
CCTeta, a novel soluble guanylyl cyclase-interacting protein. J Biol Chem (2004) 0.92
Proteomic modification by nitric oxide. J Pharmacol Sci (2006) 0.92
Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. Nitric Oxide (2009) 0.90
NO-cGMP signaling in development and stem cells. Mol Genet Metab (2005) 0.89
The placental cholinergic system: localization to the cytotrophoblast and modulation of nitric oxide. Cell Commun Signal (2006) 0.87
RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase. Nitric Oxide (2011) 0.86
CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line. Proc Natl Acad Sci U S A (2003) 0.86
Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells. J Neurosci Methods (2011) 0.86
Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis. Proc Natl Acad Sci U S A (2005) 0.85
Nitric oxide-cyclic GMP signaling in stem cell differentiation. Free Radic Biol Med (2011) 0.85
Vascular dilation by paeonol--a mechanism study. Vascul Pharmacol (2010) 0.84
NOS-2 signaling and cancer therapy. IUBMB Life (2012) 0.84
Dynamic interplay between nitration and phosphorylation of tubulin cofactor B in the control of microtubule dynamics. Proc Natl Acad Sci U S A (2007) 0.83
Nitric oxide signaling in vascular biology. J Am Soc Hypertens (2010) 0.82
Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway. Protein Cell (2012) 0.82
Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells. Stem Cells Dev (2010) 0.82
LPS/IFNgamma-induced RAW 264.7 apoptosis is regulated by both nitric oxide-dependent and -independent pathways involving JNK and the Bcl-2 family. Cell Cycle (2007) 0.82
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter. Cancer Cell Int (2011) 0.81
Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma. Mol Pharmacol (2011) 0.81
The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion. Eur J Pharmacol (2009) 0.81
Mass spectrometry-based relative quantification of human neutrophil peptides 1, 2, and 3 from biological samples. Mol Immunol (2005) 0.80
Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells. PLoS One (2012) 0.80
The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum. J Pharmacol Exp Ther (2005) 0.79
Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase alpha1 gene regulation and cGMP synthesis. Am J Physiol Cell Physiol (2005) 0.79
Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide (2003) 0.78
The excitement and rewards of research with our discovery of some of the biological effects of nitric oxide. Circ Res (2003) 0.77
Nitric oxide signaling and neural stem cell differentiation in peripheral nerve regeneration. Eplasty (2010) 0.77
Novel pyridopyrimidine derivatives as inhibitors of stable toxin a (STa) induced cGMP synthesis. Bioorg Med Chem Lett (2009) 0.77
Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem (2016) 0.75
sGC-cGMP signaling: target for anticancer therapy. Adv Exp Med Biol (2014) 0.75
Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein-HBx requires MTA1 coregulator. J Biol Chem (2017) 0.75
Ferid Murad, MD, PhD: a conversation with the editor. Am J Cardiol (2004) 0.75
Heart of science. Nature (2011) 0.75